Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
about
New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials.Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before-after study with parallel group comparisons.Psychological issues and cognitive impairment in adults with familial hypercholesterolemia.Prognostic value of PCSK9 levels in patients with acute coronary syndromes.Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up.Metabolic syndrome, diabetes and inadequate lifestyle in first-degree relatives of acute myocardial infarction survivors younger than 45 years old.Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes.Familial hypercholesterolaemia in patients with ischaemic stroke or transient ischaemic attack.European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk.Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome.Registries, codifications and cardiovascular outcomes in familial hypercholesterolaemiaFamilial Hypercholesterolaemia Diagnosis and ManagementThe evolving model of care for familial hypercholesterolaemiaResponse: Serum Levels of PCSK9 Are Associated with Coronary Angiographic Severity in Patients with Acute Coronary Syndrome (Diabetes Metab J 2018;42:207-14)
P2860
Q36366067-50C92989-FABE-46FA-B047-4D48FEAB2AB9Q37312351-934B549E-F2C1-454C-9256-39A9FD2D8A88Q39354282-EFA09661-EC39-49AF-AC20-ADC92C0B2848Q41061002-B5301A93-4AE4-4EC5-B5A6-1BD5383DDF09Q41544724-004B0731-8B53-4B62-9A69-323791C979ABQ43067844-C8166524-A534-47A1-92B5-A48D5D470AECQ47093861-FC05B7FF-CD2D-4778-8413-86E65233C6B9Q47613511-7BCBED04-BE0F-4C32-93C6-300AB31471F7Q47638420-283DAD4F-872E-4663-A8B5-553610CF8E20Q52845873-50EEF026-3BEA-4413-8F95-57FAFE3B1440Q54940707-09C5349F-9349-4D19-8CB8-7D06016EF89EQ57293348-8E5CF811-9704-4D43-AC5A-43FD65FD6050Q57495857-664282FE-12D8-41AE-B2B6-7C601AD01DD8Q58008155-00A6725B-8AA4-4FEC-BA0D-60B4F369E0D1Q58730027-3B8D718A-680A-4D6C-A154-7537EB3D11E4
P2860
Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prevalence and management of f ...... with acute coronary syndromes.
@en
type
label
Prevalence and management of f ...... with acute coronary syndromes.
@en
prefLabel
Prevalence and management of f ...... with acute coronary syndromes.
@en
P2093
P2860
P50
P356
P1476
Prevalence and management of f ...... with acute coronary syndromes.
@en
P2093
Baris Gencer
Christian M Matter
Christian M Schmied
François Mach
Nicolas Rodondi
Olivier Muller
Pierre Vogt
Roland Klingenberg
P2860
P304
P356
10.1093/EURHEARTJ/EHV289
P577
2015-07-04T00:00:00Z